) The overall goal of the Tobacco Related Malignancies Program is to decrease the incidence, morbidity, and mortality of tobacco induced cancers of the aerodigestive tract. The Program is comprised of 28 investigators with interests in various aspects of carcinogenesis, genetics, cell signaling/biology, clinical trials and primary prevention/screening/early detection. The Program includes both basic and clinical scientists with complementary interests. Clinical specialities include Medical Oncology, Radiation Oncology, Pathology, Pulmonary Medicine, General Internal Medicine, Psychiatry, Immunology, Dentistry, Head and Neck and Thoracic Surgery. Interactions between members are promoted by a twice-monthly research seminar, day-long or half-day symposia and individual outside speakers. A weekly Pulmonary/Thoracic/Oncology multidisciplinary conference and a weekly Head and Neck Tumor conference promote the enrollment of patients onto therapeutic trials. A Career Development Program has been successful in supporting young faculty members who have gone on to careers in research related to tobacco induced cancer. A Developmental Program has supported pilot projects, several of which have subsequently resulted in independent funding. Several novel therapeutic strategies based on basic and preclinical work at our institution are now being translated to human trials, including one supported by an NCI RAID. In addition to individual research grants, interactions between program members have resulted in several multi-investigator proposals, including a Specialized Program of Research Excellence in Lung Cancer, Genetic Epidemiology of Lung Cancer Consortium, Lung Cancer Biomarkers and Chemoprevention Consortium, a Biomarkers Development Component of the Early Detection Research Network and an NCI/NIDA Transdisciplinary Tobacco Use Research Center; all but the last of these were fully funded. Several parts of the latter were funded as were several other tobacco projects described in the Clinical and Community Prevention and Control Programs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA046934-14
Application #
6488584
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
1988-03-01
Project End
2006-01-31
Budget Start
Budget End
Support Year
14
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Kim, Seongsoon; Park, Donghyeon; Choi, Yonghwa et al. (2018) A Pilot Study of Biomedical Text Comprehension using an Attention-Based Deep Neural Reader: Design and Experimental Analysis. JMIR Med Inform 6:e2
Altieri, Lisa; Miller, Kimberly A; Huh, Jimi et al. (2018) Prevalence of sun protection behaviors in Hispanic youth residing in a high ultraviolet light environment. Pediatr Dermatol 35:e52-e54
Kwak, Jeff W; Laskowski, Jennifer; Li, Howard Y et al. (2018) Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression. Cancer Res 78:143-156
Hoefert, Jaimee E; Bjerke, Glen A; Wang, Dongmei et al. (2018) The microRNA-200 family coordinately regulates cell adhesion and proliferation in hair morphogenesis. J Cell Biol 217:2185-2204
Riemondy, Kent A; Gillen, Austin E; White, Emily A et al. (2018) Dynamic temperature-sensitive A-to-I RNA editing in the brain of a heterothermic mammal during hibernation. RNA 24:1481-1495
Sclafani, Robert A; Hesselberth, Jay R (2018) O Cdc7 kinase where art thou? Curr Genet 64:677-680
Shearn, Colin T; Orlicky, David J; Petersen, Dennis R (2018) Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease. Exp Mol Pathol 104:1-8
Kim, Jihye; Yoo, Minjae; Shin, Jimin et al. (2018) Systems Pharmacology-Based Approach of Connecting Disease Genes in Genome-Wide Association Studies with Traditional Chinese Medicine. Int J Genomics 2018:7697356
Coleman, Carrie B; Lang, Julie; Sweet, Lydia A et al. (2018) Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice. J Virol 92:
Petersen, Dennis R; Orlicky, David J; Roede, James R et al. (2018) Aberrant expression of redox regulatory proteins in patients with concomitant primary Sclerosing cholangitis/inflammatory bowel disease. Exp Mol Pathol 105:32-36

Showing the most recent 10 out of 1634 publications